FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901888313> ?p ?o ?g. }

• W2901888313 endingPage "151" @default.
• W2901888313 startingPage "144" @default.
• W2901888313 abstract "Background The aim of this study is to identify, in patients with peripheral artery disease and intermittent claudication (IC), the reproducibility of heart rate (HR), blood pressure (BP), rate pressure product, heart rate variability (HRV), and forearm and calf blood flow (BF) and vasodilatory assessments. Methods Twenty-nine patients with IC underwent test and retest sessions, 8–12 days apart. During each session, HR, BP, HRV, BF, and vasodilatory responses were measured by electrocardiogram, auscultation, spectral analysis of HRV (low frequency, LFR-R; high frequency, HFR-R), and strain gauge plethysmography (baseline BF, post-occlusion BF, post-occlusion area under the curve). Reproducibility was determined by intra-class correlation coefficient (ICC), typical error, coefficient of variation (CV), and limits of agreement. Results The ICC for HR and BP was >0.8 with CV <9%. For most HRV measures, ICC was >0.9 while CV was <7%, except for LF/HF (ICC = 0.737, CV = 93.8%). The ICC for forearm and calf baseline BF assessments was >0.9 while CV was <19%; variable ICC and CV for vasodilatory responses were exhibited for calf (0.653–0.770, 35.2–37.7%) and forearm (0.169–0.265, 46.2–55.5%). Conclusions In male patients with IC, systemic hemodynamics (HR and BP), cardiac autonomic modulation (LFR-R and HFR-R), and forearm and calf baseline BF assessments exhibited excellent reproducibility, whereas the level of reproducibility for vasodilatory responses were moderate to poor. Assessment reproducibility has highlighted appropriate clinical tools for the regular monitoring of disease/intervention progression in patients with IC. The aim of this study is to identify, in patients with peripheral artery disease and intermittent claudication (IC), the reproducibility of heart rate (HR), blood pressure (BP), rate pressure product, heart rate variability (HRV), and forearm and calf blood flow (BF) and vasodilatory assessments. Twenty-nine patients with IC underwent test and retest sessions, 8–12 days apart. During each session, HR, BP, HRV, BF, and vasodilatory responses were measured by electrocardiogram, auscultation, spectral analysis of HRV (low frequency, LFR-R; high frequency, HFR-R), and strain gauge plethysmography (baseline BF, post-occlusion BF, post-occlusion area under the curve). Reproducibility was determined by intra-class correlation coefficient (ICC), typical error, coefficient of variation (CV), and limits of agreement. The ICC for HR and BP was >0.8 with CV <9%. For most HRV measures, ICC was >0.9 while CV was <7%, except for LF/HF (ICC = 0.737, CV = 93.8%). The ICC for forearm and calf baseline BF assessments was >0.9 while CV was <19%; variable ICC and CV for vasodilatory responses were exhibited for calf (0.653–0.770, 35.2–37.7%) and forearm (0.169–0.265, 46.2–55.5%). In male patients with IC, systemic hemodynamics (HR and BP), cardiac autonomic modulation (LFR-R and HFR-R), and forearm and calf baseline BF assessments exhibited excellent reproducibility, whereas the level of reproducibility for vasodilatory responses were moderate to poor. Assessment reproducibility has highlighted appropriate clinical tools for the regular monitoring of disease/intervention progression in patients with IC." @default.
• W2901888313 created "2018-11-29" @default.
• W2901888313 creator A5003563411 @default.
• W2901888313 creator A5015234204 @default.
• W2901888313 creator A5016172208 @default.
• W2901888313 creator A5023453707 @default.
• W2901888313 creator A5024457837 @default.
• W2901888313 creator A5049613454 @default.
• W2901888313 creator A5055073534 @default.
• W2901888313 creator A5062356183 @default.
• W2901888313 creator A5071399371 @default.
• W2901888313 date "2019-05-01" @default.
• W2901888313 modified "2023-09-24" @default.
• W2901888313 title "Reproducibility of Hemodynamic, Cardiac Autonomic Modulation, and Blood Flow Assessments in Patients with Intermittent Claudication" @default.
• W2901888313 cites W1247984910 @default.
• W2901888313 cites W1258068744 @default.
• W2901888313 cites W126556082 @default.
• W2901888313 cites W1839386982 @default.
• W2901888313 cites W1891216974 @default.
• W2901888313 cites W1949884442 @default.
• W2901888313 cites W1972677582 @default.
• W2901888313 cites W1974626488 @default.
• W2901888313 cites W1980756938 @default.
• W2901888313 cites W1997404873 @default.
• W2901888313 cites W2002016727 @default.
• W2901888313 cites W2015795623 @default.
• W2901888313 cites W2023826463 @default.
• W2901888313 cites W2036056961 @default.
• W2901888313 cites W2040878891 @default.
• W2901888313 cites W2041660097 @default.
• W2901888313 cites W2042530995 @default.
• W2901888313 cites W2058533384 @default.
• W2901888313 cites W2059009042 @default.
• W2901888313 cites W2062939365 @default.
• W2901888313 cites W2069490874 @default.
• W2901888313 cites W2072450200 @default.
• W2901888313 cites W2073976648 @default.
• W2901888313 cites W2084299295 @default.
• W2901888313 cites W2094646093 @default.
• W2901888313 cites W2101549027 @default.
• W2901888313 cites W2110101054 @default.
• W2901888313 cites W2116008500 @default.
• W2901888313 cites W2125109199 @default.
• W2901888313 cites W2141018820 @default.
• W2901888313 cites W2142164422 @default.
• W2901888313 cites W2144985796 @default.
• W2901888313 cites W2148374679 @default.
• W2901888313 cites W2149816869 @default.
• W2901888313 cites W2151656305 @default.
• W2901888313 cites W2153802091 @default.
• W2901888313 cites W2163424852 @default.
• W2901888313 cites W2163463787 @default.
• W2901888313 cites W2163991165 @default.
• W2901888313 cites W2166977140 @default.
• W2901888313 cites W2266830123 @default.
• W2901888313 cites W2285072859 @default.
• W2901888313 cites W2335024175 @default.
• W2901888313 cites W2419642350 @default.
• W2901888313 cites W2554660886 @default.
• W2901888313 cites W2746350865 @default.
• W2901888313 cites W601585328 @default.
• W2901888313 cites W2428505212 @default.
• W2901888313 doi "https://doi.org/10.1016/j.avsg.2018.08.089" @default.
• W2901888313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30476599" @default.
• W2901888313 hasPublicationYear "2019" @default.
• W2901888313 type Work @default.
• W2901888313 sameAs 2901888313 @default.
• W2901888313 citedByCount "0" @default.
• W2901888313 crossrefType "journal-article" @default.
• W2901888313 hasAuthorship W2901888313A5003563411 @default.
• W2901888313 hasAuthorship W2901888313A5015234204 @default.
• W2901888313 hasAuthorship W2901888313A5016172208 @default.
• W2901888313 hasAuthorship W2901888313A5023453707 @default.
• W2901888313 hasAuthorship W2901888313A5024457837 @default.
• W2901888313 hasAuthorship W2901888313A5049613454 @default.
• W2901888313 hasAuthorship W2901888313A5055073534 @default.
• W2901888313 hasAuthorship W2901888313A5062356183 @default.
• W2901888313 hasAuthorship W2901888313A5071399371 @default.
• W2901888313 hasBestOaLocation W29018883132 @default.
• W2901888313 hasConcept C105795698 @default.
• W2901888313 hasConcept C126322002 @default.
• W2901888313 hasConcept C141071460 @default.
• W2901888313 hasConcept C164705383 @default.
• W2901888313 hasConcept C178853913 @default.
• W2901888313 hasConcept C2777953023 @default.
• W2901888313 hasConcept C2778213512 @default.
• W2901888313 hasConcept C2780214079 @default.
• W2901888313 hasConcept C33923547 @default.
• W2901888313 hasConcept C71635504 @default.
• W2901888313 hasConcept C71924100 @default.
• W2901888313 hasConcept C84393581 @default.
• W2901888313 hasConcept C89838059 @default.
• W2901888313 hasConcept C9893847 @default.
• W2901888313 hasConceptScore W2901888313C105795698 @default.
• W2901888313 hasConceptScore W2901888313C126322002 @default.
• W2901888313 hasConceptScore W2901888313C141071460 @default.
• W2901888313 hasConceptScore W2901888313C164705383 @default.
• W2901888313 hasConceptScore W2901888313C178853913 @default.

• next